Alcoholic Liver Disease: Pathogenesis and Current Management

Area of Science:

• Hepatology
• Toxicology
• Gastroenterology

Background:

• Excessive alcohol consumption is a significant global health issue.
• The liver is the primary organ affected by alcohol due to ethanol metabolism.
• Chronic alcohol abuse leads to a spectrum of liver damage, including steatosis, hepatitis, and fibrosis/cirrhosis.

Purpose of the Study:

• To outline the spectrum of liver injury caused by excessive alcohol consumption.
• To describe the pathological progression of alcoholic liver disease.
• To highlight the current therapeutic limitations and strategies for alcoholic liver disease.

Main Methods:

• Review of existing literature on alcohol-induced liver injury.
• Pathological description of hepatic lesions associated with chronic alcohol abuse.
• Analysis of disease modifiers and therapeutic interventions.

Main Results:

• Alcoholic liver disease progresses through stages: steatosis (fatty liver), steatohepatitis (inflammation), fibrosis (scarring), and potentially cirrhosis (advanced scarring) and liver failure.
• Approximately 35% of problem drinkers develop advanced liver disease, influenced by various disease modifiers.
• No FDA-approved pharmacological or nutritional therapies currently exist for alcoholic liver disease.

Conclusions:

• Alcoholic liver disease encompasses a range of conditions from fatty liver to cirrhosis.
• Abstinence from alcohol is a critical component of management.
• Liver transplantation is the definitive treatment for end-stage alcoholic liver disease.